O	O	O	0	3	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	4	8	role	role	I-NP	NN	O	0	ROOT	O
O	O	O	9	11	of	of	B-PP	IN	O	2	NMOD	O
T1	B-Entity	B-Entity	12	19	nuclear	nuclear	B-NP	JJ	B-protein	8	NMOD	B-protein
T1	I-Entity	I-Entity	20	26	factor	factor	I-NP	NN	I-protein	8	NMOD	I-protein
T1	I-Entity	I-Entity	26	27	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T1	I-Entity	I-Entity	27	32	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T1	I-Entity	I-Entity	33	34	B	B	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	O	35	37	in	in	B-PP	IN	O	2	NMOD	O
T2	B-Entity	B-Entity	38	46	cytokine	cytokine	B-NP	NN	B-DNA	12	NMOD	B-DNA
T2	I-Entity	I-Entity	47	51	gene	gene	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	O	52	62	regulation	regulation	I-NP	NN	O	9	PMOD	O
O	O	O	62	63	.	.	O	.	O	2	P	O

O	O	O	65	78	Transcription	Transcription	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	79	86	factors	factor	I-NP	NNS	I-protein	3	SUB	I-protein
O	O	O	87	90	are	be	B-VP	VBP	O	0	ROOT	O
T3	B-Entity	B-Entity	91	94	DNA	DNA	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	94	95	-	-	O	HYPH	I-protein	4	NMOD	I-protein
O	O	O	95	102	binding	bind	B-VP	VBG	I-protein	7	NMOD	I-protein
O	O	O	103	111	proteins	protein	B-NP	NNS	I-protein	3	PRD	I-protein
O	O	O	112	116	that	that	B-NP	WDT	O	7	NMOD	O
O	O	O	117	125	regulate	regulate	B-VP	VBP	O	8	SBAR	O
O	O	O	126	130	gene	gene	B-NP	NN	O	11	NMOD	O
O	O	O	131	141	expression	expression	I-NP	NN	O	9	OBJ	O
O	O	O	141	142	.	.	O	.	O	3	P	O

T4	B-Entity	B-Entity	143	150	Nuclear	Nuclear	B-NP	JJ	B-protein	2	NMOD	B-protein
T4	I-Entity	I-Entity	151	157	factor	factor	I-NP	NN	I-protein	12	SUB	I-protein
T4	I-Entity	I-Entity	157	158	-	-	B-VP	HYPH	O	2	NMOD	O
T4	I-Entity	I-Entity	158	163	kappa	kappa	B-NP	NN	O	5	NMOD	O
T4	I-Entity	I-Entity	164	165	B	B	I-NP	NN	O	3	OBJ	O
O	O	O	166	167	(	(	O	(	O	11	DEP	O
T5	B-Entity	B-Entity	167	169	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
T5	I-Entity	I-Entity	169	170	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T5	I-Entity	I-Entity	170	175	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T5	I-Entity	I-Entity	176	177	B	B	I-NP	NN	I-protein	11	DEP	I-protein
O	O	O	177	178	)	)	O	)	O	5	NMOD	O
O	O	O	179	181	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	182	183	a	a	B-NP	DT	O	16	NMOD	O
O	O	O	184	192	critical	critical	I-NP	JJ	O	16	NMOD	O
O	O	O	193	206	transcription	transcription	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	207	213	factor	factor	I-NP	NN	I-protein	12	PRD	I-protein
O	O	O	214	217	for	for	B-PP	IN	O	16	NMOD	O
O	O	O	218	225	maximal	maximal	B-NP	JJ	O	19	NMOD	O
O	O	O	226	236	expression	expression	I-NP	NN	O	17	PMOD	O
O	O	O	237	239	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	240	244	many	many	B-NP	JJ	O	20	PMOD	O
O	O	O	245	254	cytokines	cytokine	I-NP	NNS	B-protein	21	NMOD	B-protein
O	O	O	255	259	that	that	B-NP	WDT	O	21	NMOD	O
O	O	O	260	263	are	be	B-VP	VBP	O	23	SBAR	O
O	O	O	264	272	involved	involve	I-VP	VBN	O	24	VC	O
O	O	O	273	275	in	in	B-PP	IN	O	25	VMOD	O
O	O	O	276	279	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	280	292	pathogenesis	pathogenesis	I-NP	NN	O	26	PMOD	O
O	O	O	293	295	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	296	308	inflammatory	inflammatory	B-NP	JJ	O	31	NMOD	O
O	O	O	309	317	diseases	disease	I-NP	NNS	O	29	PMOD	O
O	O	O	317	318	,	,	O	,	O	31	P	O
O	O	O	319	323	such	such	B-PP	JJ	O	34	PMOD	O
O	O	O	324	326	as	as	I-PP	IN	O	31	NMOD	O
O	O	O	327	332	adult	adult	B-NP	JJ	O	38	NMOD	O
O	O	O	333	344	respiratory	respiratory	I-NP	JJ	O	38	NMOD	O
O	O	O	345	353	distress	distress	I-NP	NN	O	38	NMOD	O
O	O	O	354	362	syndrome	syndrome	I-NP	NN	O	44	NMOD	O
O	O	O	363	364	(	(	O	(	O	41	DEP	O
O	O	O	364	368	ARDS	ARDS	B-NP	NN	O	41	DEP	O
O	O	O	368	369	)	)	O	)	O	38	NMOD	O
O	O	O	370	373	and	and	O	CC	O	44	NMOD	O
O	O	O	374	380	sepsis	sepsis	B-NP	NN	O	44	NMOD	O
O	O	O	381	389	syndrome	syndrome	I-NP	NN	O	34	PMOD	O
O	O	O	389	390	.	.	O	.	O	12	P	O

O	O	O	391	401	Activation	Activation	B-NP	NN	O	3	NMOD	O
O	O	O	402	405	and	and	I-NP	CC	O	3	NMOD	O
O	O	O	406	416	regulation	regulation	I-NP	NN	O	9	SUB	O
O	O	O	417	419	of	of	B-PP	IN	O	3	NMOD	O
T6	B-Entity	B-Entity	420	422	NF	NF	B-NP	NN	B-protein	8	NMOD	B-protein
T6	I-Entity	I-Entity	422	423	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T6	I-Entity	I-Entity	423	428	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T6	I-Entity	I-Entity	429	430	B	B	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	O	431	434	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	435	442	tightly	tightly	I-VP	RB	O	9	VMOD	O
O	O	O	443	453	controlled	control	I-VP	VBN	O	9	VC	O
O	O	O	454	456	by	by	B-PP	IN	O	11	VMOD	O
O	O	O	457	458	a	a	B-NP	DT	O	14	NMOD	O
O	O	O	459	464	group	group	I-NP	NN	O	12	PMOD	O
O	O	O	465	467	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	468	478	inhibitory	inhibitory	B-NP	JJ	B-protein	17	NMOD	B-protein
O	O	O	479	487	proteins	protein	I-NP	NNS	I-protein	15	PMOD	I-protein
O	O	O	488	489	(	(	O	(	O	22	DEP	O
O	O	O	489	490	I	I	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	491	496	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	497	498	B	B	I-NP	NN	I-protein	22	DEP	I-protein
O	O	O	498	499	)	)	O	)	O	17	NMOD	O
O	O	O	500	504	that	that	B-NP	WDT	O	17	NMOD	O
O	O	O	505	514	sequester	sequester	B-VP	VBP	O	23	SBAR	O
T7	B-Entity	B-Entity	515	517	NF	NF	B-NP	NN	B-protein	28	NMOD	B-protein
T7	I-Entity	I-Entity	517	518	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T7	I-Entity	I-Entity	518	523	kappa	kappa	I-NP	NN	I-protein	28	NMOD	I-protein
T7	I-Entity	I-Entity	524	525	B	B	I-NP	NN	I-protein	24	OBJ	I-protein
O	O	O	526	528	in	in	B-PP	IN	O	28	NMOD	O
O	O	O	529	532	the	the	B-NP	DT	O	31	NMOD	O
O	O	O	533	542	cytoplasm	cytoplasm	I-NP	NN	O	29	PMOD	O
O	O	O	543	545	of	of	B-PP	IN	O	31	NMOD	O
O	O	O	546	552	immune	immune	B-NP	JJ	B-cell_type	37	NMOD	B-cell_type
O	O	O	552	553	/	/	I-NP	SYM	I-cell_type	37	P	I-cell_type
O	O	O	553	565	inflammatory	inflammatory	I-NP	JJ	I-cell_type	37	NMOD	I-cell_type
O	O	O	566	574	effector	effector	I-NP	NN	I-cell_type	37	NMOD	I-cell_type
O	O	O	575	580	cells	cell	I-NP	NNS	I-cell_type	32	PMOD	I-cell_type
O	O	O	580	581	.	.	O	.	O	9	P	O

T8	B-Entity	B-Entity	582	584	NF	NF	B-NP	NN	B-protein	5	NMOD	B-protein
T8	I-Entity	I-Entity	584	585	-	-	I-NP	HYPH	I-protein	5	NMOD	I-protein
T8	I-Entity	I-Entity	585	590	kappa	kappa	I-NP	NN	I-protein	5	NMOD	I-protein
T8	I-Entity	I-Entity	591	592	B	B	I-NP	NN	I-protein	5	NMOD	I-protein
O	O	O	593	603	activation	activation	I-NP	NN	O	6	SUB	O
O	O	O	604	612	involves	involve	B-VP	VBZ	O	0	ROOT	O
O	O	O	613	621	signaled	signal	I-VP	VBN	O	8	NMOD	O
O	O	O	622	637	phosphorylation	phosphorylation	B-NP	NN	O	13	NMOD	O
O	O	O	637	638	,	,	O	,	O	13	P	O
O	O	O	639	653	ubiquitination	ubiquitination	B-NP	NN	O	13	NMOD	O
O	O	O	653	654	,	,	O	,	O	13	P	O
O	O	O	655	658	and	and	O	CC	O	13	NMOD	O
O	O	O	659	670	proteolysis	proteolysis	B-NP	NN	O	6	OBJ	O
O	O	O	671	673	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	674	675	I	I	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	O	676	681	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	O	682	683	B	B	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	O	683	684	.	.	O	.	O	6	P	O

O	O	O	685	694	Liberated	Liberate	B-NP	VBN	O	6	NMOD	O
T9	B-Entity	B-Entity	695	697	NF	NF	I-NP	NN	B-protein	5	NMOD	B-protein
T9	I-Entity	I-Entity	697	698	-	-	B-NP	HYPH	I-protein	5	P	I-protein
T9	I-Entity	I-Entity	698	703	kappa	kappa	I-NP	NN	I-protein	5	NMOD	I-protein
T9	I-Entity	I-Entity	704	705	B	B	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	706	714	migrates	migrate	I-NP	NNS	O	0	ROOT	O
O	O	O	715	717	to	to	B-PP	TO	O	6	VMOD	O
O	O	O	718	721	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	722	729	nucleus	nucleus	I-NP	NN	O	7	PMOD	O
O	O	O	729	730	,	,	O	,	O	9	P	O
O	O	O	731	736	where	where	B-ADVP	WRB	O	9	NMOD	O
O	O	O	737	739	it	it	B-NP	PRP	O	13	SUB	O
O	O	O	740	745	binds	bind	B-VP	VBZ	O	11	SBAR	O
O	O	O	746	748	to	to	B-PP	TO	O	13	VMOD	O
T10	B-Entity	B-Entity	749	757	specific	specific	B-NP	JJ	B-DNA	17	NMOD	B-DNA
T10	I-Entity	I-Entity	758	766	promoter	promoter	I-NP	NN	I-DNA	17	NMOD	I-DNA
T10	I-Entity	I-Entity	767	772	sites	site	I-NP	NNS	I-DNA	14	PMOD	I-DNA
O	O	O	773	776	and	and	O	CC	O	13	VMOD	O
O	O	O	777	786	activates	activate	B-VP	VBZ	O	13	VMOD	O
O	O	O	787	791	gene	gene	B-NP	NN	O	21	NMOD	O
O	O	O	792	805	transcription	transcription	I-NP	NN	O	19	OBJ	O
O	O	O	805	806	.	.	O	.	O	6	P	O

O	O	O	807	810	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	811	821	activation	activation	I-NP	NN	O	8	SUB	O
O	O	O	822	824	of	of	B-PP	IN	O	2	NMOD	O
T11	B-Entity	B-Entity	825	827	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
T11	I-Entity	I-Entity	827	828	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T11	I-Entity	I-Entity	828	833	kappa	kappa	I-NP	NN	I-protein	7	NMOD	I-protein
T11	I-Entity	I-Entity	834	835	B	B	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	O	836	845	initiates	initiate	B-VP	VBZ	O	0	ROOT	O
O	O	O	846	850	both	both	O	CC	O	14	NMOD	O
O	O	O	851	864	extracellular	extracellular	B-NP	JJ	O	14	NMOD	O
O	O	O	865	868	and	and	I-NP	CC	O	14	NMOD	O
O	O	O	869	882	intracellular	intracellular	I-NP	JJ	O	14	NMOD	O
O	O	O	883	893	regulatory	regulatory	I-NP	JJ	O	14	NMOD	O
O	O	O	894	900	events	event	I-NP	NNS	O	8	OBJ	O
O	O	O	901	905	that	that	B-NP	WDT	O	14	NMOD	O
O	O	O	906	912	result	result	B-VP	VBP	O	15	SBAR	O
O	O	O	913	915	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	916	930	autoregulation	autoregulation	B-NP	NN	O	17	PMOD	O
O	O	O	931	933	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	934	937	the	the	B-NP	DT	O	22	NMOD	O
O	O	O	938	950	inflammatory	inflammatory	I-NP	JJ	O	22	NMOD	O
O	O	O	951	958	cascade	cascade	I-NP	NN	O	19	PMOD	O
O	O	O	959	966	through	through	B-PP	IN	O	18	NMOD	O
O	O	O	967	977	modulation	modulation	B-NP	NN	O	23	PMOD	O
O	O	O	978	980	of	of	B-PP	IN	O	24	NMOD	O
T12	B-Entity	B-Entity	981	983	NF	NF	B-NP	NN	B-protein	30	NMOD	B-protein
T12	I-Entity	I-Entity	983	984	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T12	I-Entity	I-Entity	984	989	kappa	kappa	I-NP	NN	I-protein	30	NMOD	I-protein
T12	I-Entity	I-Entity	990	991	B	B	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	992	1002	activation	activation	I-NP	NN	O	25	PMOD	O
O	O	O	1002	1003	.	.	O	.	O	8	P	O

O	O	O	1004	1012	Recently	Recently	B-ADVP	RB	O	9	VMOD	O
O	O	O	1012	1013	,	,	O	,	O	9	P	O
O	O	O	1014	1024	activation	activation	B-NP	NN	O	9	SUB	O
O	O	O	1025	1027	of	of	B-PP	IN	O	3	NMOD	O
T13	B-Entity	B-Entity	1028	1030	NF	NF	B-NP	NN	B-protein	8	NMOD	B-protein
T13	I-Entity	I-Entity	1030	1031	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T13	I-Entity	I-Entity	1031	1036	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T13	I-Entity	I-Entity	1037	1038	B	B	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	O	1039	1042	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	1043	1047	been	be	I-VP	VBN	O	9	VC	O
O	O	O	1048	1054	linked	link	I-VP	VBN	O	10	VC	O
O	O	O	1055	1057	to	to	B-PP	TO	O	11	VMOD	O
O	O	O	1058	1062	ARDS	ARDS	B-NP	NN	O	12	PMOD	O
O	O	O	1063	1066	and	and	O	CC	O	9	VMOD	O
O	O	O	1067	1070	has	have	B-VP	VBZ	O	9	VMOD	O
O	O	O	1071	1075	been	be	I-VP	VBN	O	15	VC	O
O	O	O	1076	1081	shown	show	I-VP	VBN	O	16	VC	O
O	O	O	1082	1084	to	to	I-VP	TO	O	19	VMOD	O
O	O	O	1085	1087	be	be	I-VP	VB	O	17	VMOD	O
O	O	O	1088	1089	a	a	B-NP	DT	O	23	NMOD	O
O	O	O	1090	1098	critical	critical	I-NP	JJ	O	23	NMOD	O
O	O	O	1099	1107	proximal	proximal	I-NP	JJ	O	23	NMOD	O
O	O	O	1108	1112	step	step	I-NP	NN	O	19	PRD	O
O	O	O	1113	1115	in	in	B-PP	IN	O	19	VMOD	O
O	O	O	1116	1119	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	1120	1130	initiation	initiation	I-NP	NN	O	24	PMOD	O
O	O	O	1131	1133	of	of	B-PP	IN	O	26	NMOD	O
O	O	O	1134	1146	neutrophilic	neutrophilic	B-NP	JJ	O	29	NMOD	O
O	O	O	1147	1159	inflammation	inflammation	I-NP	NN	O	27	PMOD	O
O	O	O	1160	1162	in	in	B-PP	IN	O	26	NMOD	O
O	O	O	1163	1169	animal	animal	B-NP	NN	O	32	NMOD	O
O	O	O	1170	1176	models	model	I-NP	NNS	O	30	PMOD	O
O	O	O	1176	1177	.	.	O	.	O	9	P	O

O	O	O	1178	1188	Activation	Activation	B-NP	NN	O	7	SUB	O
O	O	O	1189	1191	of	of	B-PP	IN	O	1	NMOD	O
T14	B-Entity	B-Entity	1192	1194	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T14	I-Entity	I-Entity	1194	1195	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T14	I-Entity	I-Entity	1195	1200	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T14	I-Entity	I-Entity	1201	1202	B	B	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	1203	1206	can	can	B-VP	MD	O	0	ROOT	O
O	O	O	1207	1209	be	be	I-VP	VB	O	7	VC	O
O	O	O	1210	1219	inhibited	inhibit	I-VP	VBN	O	8	VC	O
O	O	O	1220	1222	in	in	B-ADVP	FW	O	9	VMOD	O
O	O	O	1223	1227	vivo	vivo	I-ADVP	FW	O	10	AMOD	O
O	O	O	1228	1230	by	by	B-PP	IN	O	9	VMOD	O
O	O	O	1231	1240	treatment	treatment	B-NP	NN	O	12	PMOD	O
O	O	O	1241	1245	with	with	B-PP	IN	O	13	NMOD	O
O	O	O	1246	1258	antioxidants	antioxidant	B-NP	NNS	O	21	NMOD	O
O	O	O	1258	1259	,	,	O	,	O	21	P	O
O	O	O	1260	1275	corticosteroids	corticosteroid	B-NP	NNS	O	21	NMOD	O
O	O	O	1275	1276	,	,	O	,	O	21	P	O
O	O	O	1277	1280	and	and	O	CC	O	21	NMOD	O
O	O	O	1281	1284	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	1285	1294	induction	induction	I-NP	NN	O	14	PMOD	O
O	O	O	1295	1297	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	1298	1307	endotoxin	endotoxin	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	1308	1317	tolerance	tolerance	I-NP	NN	O	22	PMOD	O
O	O	O	1317	1318	.	.	O	.	O	7	P	O

O	O	O	1319	1333	Identification	Identification	B-NP	NN	O	14	SUB	O
O	O	O	1334	1336	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	1337	1341	more	more	B-NP	RBR	O	7	NMOD	O
O	O	O	1342	1350	specific	specific	I-NP	JJ	O	7	NMOD	O
O	O	O	1351	1354	and	and	I-NP	CC	O	7	NMOD	O
O	O	O	1355	1366	efficacious	efficacious	I-NP	JJ	O	7	NMOD	O
O	O	O	1367	1377	inhibitors	inhibitor	I-NP	NNS	O	2	PMOD	O
O	O	O	1378	1380	of	of	B-PP	IN	O	7	NMOD	O
T15	B-Entity	B-Entity	1381	1383	NF	NF	B-NP	NN	B-protein	12	NMOD	B-protein
T15	I-Entity	I-Entity	1383	1384	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T15	I-Entity	I-Entity	1384	1389	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T15	I-Entity	I-Entity	1390	1391	B	B	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	1392	1402	activation	activation	I-NP	NN	O	8	PMOD	O
O	O	O	1403	1408	might	might	B-VP	MD	O	0	ROOT	O
O	O	O	1409	1414	prove	prove	I-VP	VB	O	14	VC	O
O	O	O	1415	1425	beneficial	beneficial	B-ADJP	JJ	O	15	PRD	O
O	O	O	1426	1429	for	for	B-PP	IN	O	16	AMOD	O
O	O	O	1430	1433	the	the	B-NP	DT	O	19	NMOD	O
O	O	O	1434	1443	treatment	treatment	I-NP	NN	O	17	PMOD	O
O	O	O	1444	1446	of	of	B-PP	IN	O	19	NMOD	O
O	O	O	1447	1455	cytokine	cytokine	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	O	1455	1456	-	-	O	HYPH	O	25	P	O
O	O	O	1456	1464	mediated	mediate	B-NP	VBN	O	25	NMOD	O
O	O	O	1465	1477	inflammatory	inflammatory	I-NP	JJ	O	25	NMOD	O
O	O	O	1478	1486	diseases	disease	I-NP	NNS	O	20	PMOD	O
O	O	O	1486	1487	.	.	O	.	O	14	P	O
